Detalhe da pesquisa
1.
Emerging antibody-based products.
Curr Top Microbiol Immunol
; 375: 107-26, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-22772797
2.
Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana.
MAbs
; 14(1): 2013594, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35000569
3.
Manufacturing plant-made monoclonal antibodies for research or therapeutic applications.
Methods Enzymol
; 660: 239-263, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34742392
4.
CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology.
Vaccines (Basel)
; 9(11)2021 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34835277
5.
Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle.
Vaccines (Basel)
; 9(11)2021 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34835278
6.
Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems.
Plant Biotechnol J
; 8(5): 638-54, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20514694
7.
Efficient In Vitro and In Vivo Activity of Glyco-Engineered Plant-Produced Rabies Monoclonal Antibodies E559 and 62-71-3.
PLoS One
; 11(7): e0159313, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27427976
8.
Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge.
Hum Vaccin Immunother
; 10(3): 586-95, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24378714